RHOA and Hypertension: In this experiment, we further found that Y27632 inhibited ROCK and RhoA activity caused by activation of the RhoA/ROCK pathway induced by apatinib and HSD, which may be a potential therapeutic target for the treatment of hypertension caused by apatinib and HSD.